Lexpos News

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff experts have created a new video discussing prescription charges. In this video, we provide guidance on how pharmacy teams can determine the number of charges that apply to items dispensed against NHS prescriptions. In this video, Gemma Hackett (Dispensing and Supply [...]

The post Funding & Reimbursement Shorts: Prescription charges – what does the patient pay? appeared first on Community Pharmacy England.

With the deadline now imminent, Community Pharmacy England is urging pharmacy owners to take action to finish and publish the Data Security and Protection Toolkit (DSPTK) for 2026 now and reminding them to make use of our resources to work through the process as efficiently as possible. Completion is already underway again this year – [...]

The post Data Security Toolkit: Final week left to finish it appeared first on Community Pharmacy England.

Community pharmacy leaders, MPs and health stakeholders have gathered in Westminster to discuss the future of the sector and the part it can play in delivering care closer to home. LPC Chairs from across England met in Parliament on Monday 15th June, followed by a Parliamentary reception with MPs and other stakeholders about Neighbourhood Health. [...]

The post LPC Chairs meet in Parliament to discuss pharmacy funding, reform and future strategy appeared first on Community Pharmacy England.

The UK Health Security Agency (UKHSA) and NHS England have published a letter providing further information on the Meningococcal (MenB) time limited vaccination offer. The letter follows on from the announcement last week, where the Department of Health and Social Care and NHS England announced a new community pharmacy vaccination service to provide a one-off [...]

The post MenB: UKHSA and NHS England provide further information on vac service appeared first on Community Pharmacy England.

The product information for all ACE inhibitors is being updated to strengthen the warnings on the risk of delayed-onset angioedema, which may still occur after weeks to years of use. Healthcare professionals, particularly in emergency departments, should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, [...]

The post MHRA Drug Safety Update: ACE-inhibitors appeared first on Community Pharmacy England.